Intas Biopharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 22.42 Cr
- Paid Up Capital ₹ 7.92 Cr
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2012
About Intas Biopharmaceuticals
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2005PLC047111
-
Company No.
047111
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
23 Nov 2005
-
Date of AGM
21 Aug 2012
-
Date of Balance Sheet
31 Mar 2012
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Intas Biopharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Urmish Chudgar
|
Managing Director | 23-Nov-2005 | Current |
| Jitesh Laddha | Company Secretary | 27-Aug-2010 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sanjiv Kaul
|
Director | 02-Aug-2011 | Current |
|
Binish Chudgar
|
Director | 08-Jul-2010 | Current |
|
Hasmukh Chudgar
|
Director | 16-Jan-2006 | Current |
|
Nimish Chudgar
|
Director | 16-Jan-2006 | Current |
Financial Performance of Intas Biopharmaceuticals.
Enhance accessibility to Intas Biopharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intas Biopharmaceuticals?
Unlock access to Intas Biopharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Jina Pharmaceuticals Limited.Binish Chudgar is a mutual person
-
Astron Packaging LimitedUrmish Chudgar, Binish Chudgar and 1 more are mutual person
-
Sm Herbals Private LimitedNimish Chudgar is a mutual person
-
Advanced Transfusion Medicine Research FoundationUrmish Chudgar is a mutual person
-
Accord Healthcare LimitedUrmish Chudgar, Binish Chudgar and 1 more are mutual person
-
Intas Pharmaceuticals LimitedUrmish Chudgar, Binish Chudgar and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Intas Biopharmaceuticals?
Unlock and access historical data on people associated with Intas Biopharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intas Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intas Biopharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
